Evidence map›Paper›PMID 26882996›Full record

ArticleScientific reports2016

Wnt11 Gene Therapy with Adeno-associated Virus 9 Improves Recovery from Myocardial Infarction by Modulating the Inflammatory Response.

Yoshihiro Morishita, Koichi Kobayashi, Ekaterina Klyachko, Kentaro Jujo, Kengo Maeda, Douglas W Losordo, Toyoaki Murohara

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. WNT Signaling in Cardiac and Vascular Disease.Pharmacological reviews · 2018
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yoshihiro MorishitaDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Koichi KobayashiDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Ekaterina KlyachkoFeinberg Cardiovascular Research Institute, Northwestern University School of Medicine, Chicago, IL 60611, USA.
Kentaro JujoFeinberg Cardiovascular Research Institute, Northwestern University School of Medicine, Chicago, IL 60611, USA.
Kengo MaedaDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Douglas W LosordoFeinberg Cardiovascular Research Institute, Northwestern University School of Medicine, Chicago, IL 60611, USA.
Toyoaki MuroharaDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Northwestern University · USNagoya University · JP

Funding

Therapeutic Angiogenesis in Vascular Medicine IVR01HL053354 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 1995 to 2015
$4.2M
RE-ENDOTHELIALIZATION AND RESTENOSIS IIR01HL057516 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 1997 to 2008
$3.3M
RESTENOSIS AND ENDOTHELIAL PROLIFERATIONR01HL063414 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 1999 to 2007
$2.5M
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PADR01HL077428 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2006 to 2011
$2.5M
Role of Progenitor Cells in Cardiovascular MedicineR01HL080137 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2006 to 2010
$1.9M
Novel approaches to ischemic tissue repairR01HL095874 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KISHORE, RAJ · 2009 to 2012
$1.5M
THERAPEUTIC ANGIOGENESIS IN VASCULAR MEDICINE IIR37HL053354 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI ISNER, JEFFREY · 2000 to 2001
$726k
NHLBI NIH HHS HL-53354NHLBI NIH HHS HL-57516NHLBI NIH HHS HL-63414NHLBI NIH HHS HL-77428NHLBI NIH HHS HL-80137NHLBI NIH HHS HL-95874NHLBI NIH HHS R01 HL053354NHLBI NIH HHS R01 HL063414NHLBI NIH HHS R01 HL077428NHLBI NIH HHS R01 HL080137NHLBI NIH HHS R01 HL095874NHLBI NIH HHS R37 HL053354PHS HHS HLP01-66957
6 · The paper itself

Abstract

Acute myocardial infarction induces activation of the acute phase response and infiltration of leukocytes to the infarcted area. Moreover, myocardium that is remote from ischemic area also becomes inflamed. Inflammatory reaction clears dead cells and matrix debris, while prolongation or expansion of the inflammatory response results in dysfunction following myocardial infarction. Wnt glycolipoproteins are best characterized as regulators of embryonic development. Recently several reports suggest that they also contribute to the inflammatory response in adult animals. However, the effects of Wnt proteins on myocardial infarction have not been explored. Here we show that Wnt11 expression leads to significant improvements of survival and cardiac function by suppressing infiltration of multiple kinds of inflammatory cells in infarcted heart. Wnt11 protein suppresses gene expression of inflammatory cytokines through the modulation of NF-κB in vitro. These results reveal a novel function of Wnt11 in the regulation of inflammatory response and provide a rationale for the use of Wnt11 to manipulate human diseases that are mediated by inflammation.

Indexed as

AnimalsCytokinesDependovirusDisease Models, AnimalFemaleGene Expression RegulationGenetic TherapyGenetic VectorsHumansMaleMiceMyocardial InfarctionNIH 3T3 CellsWnt ProteinsCytokinesWnt11 protein, humanWnt Proteins

Identifiers

PMID26882996
PMCPMC4756373
OpenAlexW2415819616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.